Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis Recurrence
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis Recurrence
Authors
Keywords
-
Journal
SCHIZOPHRENIA BULLETIN
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2023-11-06
DOI
10.1093/schbul/sbad145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Who has poor insight, my patient suffering from schizophrenia or myself?
- (2023) Michael Davidson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
- (2022) Johannes Schneider-Thoma et al. LANCET
- Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline
- (2022) R.M. Murray et al. SCHIZOPHRENIA RESEARCH
- Associating Violence With Schizophrenia—Risks and Biases
- (2022) Paolo Fusar-Poli et al. JAMA Psychiatry
- Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
- (2022) Christoph U. Correll et al. npj Schizophrenia
- Controversies in rheumatology: maintenance therapy with low-dose glucocorticoids in rheumatoid arthritis
- (2022) Frank Buttgereit et al. RHEUMATOLOGY
- Deinstitutionalization and the Impact of Antipsychotics Versus Policy Change
- (2022) Joni Lee Pow et al. Ethical Human Psychology and Psychiatry
- Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials
- (2022) Jan P A M Bogers et al. SCHIZOPHRENIA BULLETIN
- Long-term impact of antipsychotics: settling the controversy requires more clarity
- (2021) Awais Aftab PSYCHOLOGICAL MEDICINE
- A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
- (2021) Mark Abie Horowitz et al. SCHIZOPHRENIA BULLETIN
- Misreporting of Results of Research in Psychiatry
- (2021) Jana Bowcut et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic-induced supersensitivity – A reappraisal
- (2021) William Lugg AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Long-term effectiveness of antipsychotics
- (2021) Martin Harrow et al. PSYCHOLOGICAL MEDICINE
- Antipsychotic discontinuation and recovery: chicken or egg?
- (2021) Joseph M. Pierre et al. PSYCHOLOGICAL MEDICINE
- How Efficacious Are Antipsychotic Drugs for Schizophrenia? An Interpretation Based on 13 Effect Size Indices
- (2021) Stefan Leucht et al. SCHIZOPHRENIA BULLETIN
- Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia
- (2021) Sophie E. Legge et al. JAMA Psychiatry
- Predicting time to relapse in patients with schizophrenia according to patients’ relapse history: a historical cohort study using real-world data in Sweden
- (2021) Kristian Tore Jørgensen et al. BMC Psychiatry
- Confounding of Antipsychotic Discontinuation Studies by Withdrawal-Related Relapse
- (2021) Mark Abie Horowitz et al. SCHIZOPHRENIA BULLETIN
- The nature of schizophrenia: As broad as it is long
- (2021) Michael J. Owen et al. SCHIZOPHRENIA RESEARCH
- To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
- (2020) Marieke J. H. Begemann et al. Trials
- Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features
- (2020) Aristotle N. Voineskos et al. JAMA Psychiatry
- Digital phenotyping of negative symptoms: the relationship to clinician ratings
- (2020) Alex S Cohen et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-Analysis
- (2020) Lasse Brandt et al. Frontiers in Psychiatry
- Antipsychotics and mortality – more clarity needed
- (2020) David Taylor et al. PSYCHOLOGICAL MEDICINE
- What is Missing in Treatment Guidelines?
- (2020) William T Carpenter SCHIZOPHRENIA BULLETIN
- Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk
- (2019) Dag Alnæs et al. JAMA Psychiatry
- Cognitive Change in Schizophrenia and Other Psychoses in the Decade Following the First Episode
- (2019) Jolanta Zanelli et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pharmacological treatment of violence in schizophrenia
- (2019) Martin T. Strassnig et al. CNS SPECTRUMS
- From Many to One to Many—the Search for Causes of Psychiatric Illness
- (2019) Kenneth S. Kendler JAMA Psychiatry
- Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review
- (2019) Joanna Moncrieff et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms
- (2019) Yutaro Shimomura et al. SCHIZOPHRENIA RESEARCH
- 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
- (2018) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Very long-term outcome of schizophrenia
- (2018) Jan Volavka et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?
- (2018) Jan Józef Szczypiński et al. REVIEWS IN THE NEUROSCIENCES
- The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention
- (2018) Anthony A Grace et al. SCHIZOPHRENIA BULLETIN
- A critical analysis of recent data on the long-term outcome of antipsychotic treatment
- (2018) Joanna Moncrieff et al. PSYCHOLOGICAL MEDICINE
- Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis
- (2017) Sanna Huhtaniska et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Lifetime antipsychotic medication and cognitive performance in schizophrenia at age 43 years in a general population birth cohort
- (2017) Anja P. Husa et al. PSYCHIATRY RESEARCH
- Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis
- (2017) Regitze Sølling Wils et al. SCHIZOPHRENIA RESEARCH
- Secondary negative symptoms — A review of mechanisms, assessment and treatment
- (2017) Matthias Kirschner et al. SCHIZOPHRENIA RESEARCH
- Research on a ‘drug-centred’ approach to psychiatric drug treatment: assessing the impact of mental and behavioural alterations produced by psychiatric drugs
- (2017) J. Moncrieff Epidemiology and Psychiatric Sciences
- Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia
- (2017) Christoph U. Correll et al. JAMA Psychiatry
- Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review
- (2017) Meghan Bowtell et al. SCHIZOPHRENIA RESEARCH
- Genetic correlates of insight in schizophrenia
- (2017) Rose Mary Xavier et al. SCHIZOPHRENIA RESEARCH
- Cognitive biases associated with medical decisions: a systematic review
- (2016) Gustavo Saposnik et al. BMC Medical Informatics and Decision Making
- Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
- (2016) Robin M. Murray et al. BRITISH JOURNAL OF PSYCHIATRY
- Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era
- (2016) M. Alvarez-Jimenez et al. CNS DRUGS
- Long-term antipsychotic use and its association with outcomes in schizophrenia – the Northern Finland Birth Cohort 1966
- (2016) J.M. Moilanen et al. EUROPEAN PSYCHIATRY
- Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies
- (2015) Pál Czobor et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A Nation-Wide Study on the Percentage of Schizophrenia and Bipolar Disorder Patients Who Earn Minimum Wage or Above
- (2015) Michael Davidson et al. SCHIZOPHRENIA BULLETIN
- Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function
- (2015) Joyce Y. Guo et al. SCHIZOPHRENIA RESEARCH
- Longitudinal Changes in Total Brain Volume in Schizophrenia: Relation to Symptom Severity, Cognition and Antipsychotic Medication
- (2014) Juha Veijola et al. PLoS One
- Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study
- (2014) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
- (2014) C. Morgan et al. PSYCHOLOGICAL MEDICINE
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
- (2014) Paolo Fusar-Poli et al. SCHIZOPHRENIA BULLETIN
- Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
- (2013) Arsime Demjaha et al. AMERICAN JOURNAL OF PSYCHIATRY
- Insight and Hostility as Predictors and Correlates of Nonadherence in the European First Episode Schizophrenia Trial
- (2013) Pál Czobor et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies
- (2013) P. Fusar-Poli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Does Long-Term Treatment of Schizophrenia With Antipsychotic Medications Facilitate Recovery?
- (2013) M. Harrow et al. SCHIZOPHRENIA BULLETIN
- Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
- (2013) Stephen R. Marder et al. SCHIZOPHRENIA RESEARCH
- Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy
- (2013) Lex Wunderink et al. JAMA Psychiatry
- Antipsychotics: is it time to introduce patient choice?
- (2012) Anthony P. Morrison et al. BRITISH JOURNAL OF PSYCHIATRY
- A Randomized Trial Comparing In Person and Electronic Interventions for Improving Adherence to Oral Medications in Schizophrenia
- (2012) D. Velligan et al. SCHIZOPHRENIA BULLETIN
- Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia
- (2012) Robin Emsley et al. SCHIZOPHRENIA RESEARCH
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Long-term Antipsychotic Treatment and Brain Volumes
- (2011) Beng-Choon Ho et al. ARCHIVES OF GENERAL PSYCHIATRY
- Progressive Brain Change in Schizophrenia: A Prospective Longitudinal Study of First-Episode Schizophrenia
- (2011) Nancy C. Andreasen et al. BIOLOGICAL PSYCHIATRY
- Clinical relevance of findings in trials of antipsychotics: systematic review
- (2011) Peter Lepping et al. BRITISH JOURNAL OF PSYCHIATRY
- Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication – A 10-year follow-up of the Northern Finland 1966 Birth Cohort study
- (2011) J. Moilanen et al. EUROPEAN PSYCHIATRY
- Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)
- (2009) Michael Davidson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death
- (2009) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
- (2009) Julie Kreyenbuhl et al. SCHIZOPHRENIA BULLETIN
- Side-effects of antipsychotic medication and health-related quality of life in schizophrenia
- (2008) P. E. Bebbington et al. ACTA PSYCHIATRICA SCANDINAVICA
- Less Is More: Antipsychotic Drug Effects Are Greater with Transient Rather Than Continuous Delivery
- (2008) Anne-Noël Samaha et al. BIOLOGICAL PSYCHIATRY
- Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia
- (2008) S. Mohamed et al. SCHIZOPHRENIA BULLETIN
- Extrapolation between measures of symptom severity and change: An examination of the PANSS and CGI
- (2007) Stephen Z. Levine et al. SCHIZOPHRENIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started